Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile

Date: July 17, 2017
Pages: 56
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L0035A2F20DEN
Leaflet:

Download PDF Leaflet

Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile
Summary

Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Luminex Corp, Medical Equipment Deals By Type, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deal Details
Partnerships
Natural Molecular Testing Enters Into Licensing Agreement With Luminex
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device
Genetic Analysis Enters into Agreement with Luminex
Luminex Enters into Distribution Agreement with Bio-Techne
Affymetrix Enters into Distribution Agreement with Luminex
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP
Luminex Extends Distribution Agreement With EMD Millipore
Nanosphere Enters Into Distribution Agreement With Hitachi High-Technologies
Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
Luminex Enters Into Distribution Agreement With Life Technologies
Luminex Enters Into An Agreement With Partners HealthCare
Equity Offering
Nanosphere Raises USD10 Million in Public Offering of Shares
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock
Nanosphere Raises USD20 Million in Public Offering of Shares
Nanosphere Completes Public Offering Of Shares For US$30.2 Million
Nanosphere Completes Public Offering Of Shares For US$5 Million
Nanosphere Completes Public Offering Of Common Stock For US$29 Million
Nanosphere Completes Underwritten Public Offering Of US$34.5 Million
Asset Transactions
Luminex Plans To Sell Newborn Screening Business
Acquisition
Luminex Acquires Nanosphere in Tender Offer
Nanosphere Plans to Sell Itself
Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto US$60 Million
Luminex Completes Acquisition Of EraGen Biosciences
Luminex Corp - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance
Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results
Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance
Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance
Jul 28, 2016: Luminex Reports Second Quarter 2016 Results
May 02, 2016: Luminex Reports First Quarter 2016 Results
Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results
Product News
Apr 07, 2016: Luminex to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES System
Feb 22, 2016: Luminex Receives Medical Device License for ARIES HSV 1&2 Assay in Canada
Feb 22, 2016: Luminex Receives Medical Device License for ARIES System in Canada
Product Approvals
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES System
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Luminex Corp, Medical Equipment, Key Facts, 2016
Luminex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Luminex Corp, Medical Equipment Deals By Type, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Luminex Corp, Deals By Market, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
Natural Molecular Testing Enters Into Licensing Agreement With Luminex
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device
Genetic Analysis Enters into Agreement with Luminex
Luminex Enters into Distribution Agreement with Bio-Techne
Affymetrix Enters into Distribution Agreement with Luminex
TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP
Luminex Extends Distribution Agreement With EMD Millipore
Nanosphere Enters Into Distribution Agreement With Hitachi High-Technologies
Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
Luminex Enters Into Distribution Agreement With Life Technologies
Luminex Enters Into An Agreement With Partners HealthCare
Nanosphere Raises USD10 Million in Public Offering of Shares
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock
Nanosphere Raises USD20 Million in Public Offering of Shares
Nanosphere Completes Public Offering Of Shares For US$30.2 Million
Nanosphere Completes Public Offering Of Shares For US$5 Million
Nanosphere Completes Public Offering Of Common Stock For US$29 Million
Nanosphere Completes Underwritten Public Offering Of US$34.5 Million
Luminex Plans To Sell Newborn Screening Business
Luminex Acquires Nanosphere in Tender Offer
Nanosphere Plans to Sell Itself
Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto US$60 Million
Luminex Completes Acquisition Of EraGen Biosciences
Luminex Corp, Key Competitors
Luminex Corp, Key Employees
Luminex Corp, Other Locations
Luminex Corp, Subsidiaries

LIST OF FIGURES

Luminex Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
Luminex Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: